Trademark applications and grants for Biogen Hemophilia Inc. Biogen Hemophilia Inc has 2 trademark applications. The latest application filed is for "AVEREV THERAPEUTICS"
Patent Application | Date |
---|---|
Chimeric Clotting Factors 20170044512 - 15/221420 SALAS; Joe ;   et al. | 2017-02-16 |
Factor IX Polypeptides and Methods of Use Thereof 20160346365 - 15/043445 PIERCE; Glenn ;   et al. | 2016-12-01 |
Factor IX Polypeptides and Methods of Use Thereof 20160257943 - 14/982934 Pierce; Glenn ;   et al. | 2016-09-08 |
Factor IX Polypeptides and Methods of Use Thereof 20160243206 - 15/043457 PIERCE; Glenn ;   et al. | 2016-08-25 |
FC RECEPTOR BINDING PROTEINS 20160222112 - 14/984162 TenHoor; Christopher ;   et al. | 2016-08-04 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "AVEREV THERAPEUTICS" 87116556 |
AVEREV THERAPEUTICS 2016-07-26 |
![]() "AVEREV" 87116549 |
AVEREV 2016-07-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.